Anthrax lethal factor: Critical virulence factor of pathogenesis of anthrax toxins

Toxin Reviews

Volumn 25, Issue 1, 2006, Pages 109-124

  Kim, Joungmok ^a   Yoon, Moon Young ^a  

^a Hanyang University   (South Korea)

Author keywords

Anthrax toxin; Inhibitor screening; Lethal factor

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; ANTHRAX TOXIN; ANTIVIRUS AGENT; DS 998; EPIGALLOCATECHIN GALLATE; HYDROXAMIC ACID DERIVATIVE; ILOMASTAT; METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; NEOMYCIN; NSC 12155; NSC 357756; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG; ZINC ION;

ANALYTIC METHOD; ANTHRAX; CHEMICAL STRUCTURE; CYTOLYSIS; DRUG SCREENING; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME SPECIFICITY; HUMAN; LETHAL GENE; MACROPHAGE; NONHUMAN; REVIEW; SCREENING TEST; STRUCTURE ANALYSIS; THREE DIMENSIONAL IMAGING; VIRULENCE;

BACILLUS ANTHRACIS; POSIBACTERIA;

EID: 32844472924     PISSN: 15569543     EISSN: 15569551     Source Type: Journal    
DOI: 10.1080/15569540500320987     Document Type: Review

References (35)

1. Bardwell, A. J., Abdollahi, M., Bardwell, L. (2004). Anthrax lethal factor-cleavage products of MAPK (mitogen-activated protein kinase) kinases exhibit reduced binding to their cognate MAPKs. Biochem. J. 378:569-577.
2. Bradley, K. A., Mogridge, J., Mourez, M., Collier, R. J., Young, J. A. (2001). Identification of the cellular receptor for anthrax toxin. Nature 414:225-229.
3. Chopra, A. P., Boone, S. A., Liang, X., Duesbery, N. S. (2003) Anthrax lethal factor proteolysis and inactivation of MAPK kinase. J. Biol. Chem. 278:9402-9406.
4. Collier, R. J., Young, J. A. (2003). Anthrax toxin. Annu. Rev. Cell Dev. Biol. 19:45-70.
5. Cummings, R. T., Salowe, S. P., Cunningham, B. R., Wiltsie, J., Park, Y. W., Sonatore, L. M., Wisniewski, D., Douglas, C. M., Hermes, J. D., Scolnick, E. M. (2002). A peptide-based fluorescence resonance energy transfer assay for Bacillus anthracis lethal factor protease. Proc. Natl. Acad. Sci. USA 99:6603-6606.
6. Dell'Aica, I., Dona, M., Tonello, F., Piris, A., Mock, M., Montecucco, C., Garbisa, S. (2004). Potent inhibitors of anthrax lethal factor from green tea. EMBO Rep. 5:418-422.
7. Duesbery, N. S., Webb, C. P., Leppla, S. H., Gordon, V. M., Klimpel, K. R., Copeland, T. D., Ahn, N. G., Oskarsson, M. K., Fukasawa, K., Paull, K. D., Vande Woude, G. F. (1998). Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science 280:734-737.
8. Fridman, M.; Belakhov, V.; Lee, L. V.; Liang, F. S.; Wong, C. H.; Baasov, T. (2005). Dual effect of synthetic aminoglycosides: antibacterial activity against Bacillus anthracis and inhibition of anthrax lethal factor. Angew Chem. Int. Ed. Engl. 44:447-452.
9. Gill, D. M. (1978). In Bacterial Toxins and Cell Membranes. Academic Press: London, New York 291-332.
10. Green, B. D., Battisti, L., Koehler, T. M., Thorne, C. B., Ivins, B. E. (1985). Demostration of a capsule plasmid in Bacillus anthracis. Infect. Immun. 49:291-297.
11. Hammond, S. E., Hanna, P. C. (1998). Lethal factor active-site mutations affect catalytic activity in vitro. Infect. Immun. 66:2374-2378.
12. Kim, J., Kim, Y. M., Koo, B. S., Chae, Y. K., Yoon, M. Y. (2003). Production and proteolytic assay of lethal factor from Bacillus anthracis. Protein Expr. Purif. 30:293-300.
13. Kim, J., Chai, Y. G., Yoon, M. Y. (2004). Implication of pH in the catalytic properties of anthrax lethal factor. Biochem. Biophys. Res. Commun. 313:217-222.
14. Kim, J., Choi, M. K., Koo, B. S., Yoon, M. Y. (2005). Development of high-throughput assay of lethal factor using native substrate. Anal. Biochem. 341:33-39.
15. Lee, L. V., Bower, K. E., Liang, F. S., Shi, J., Wu, D., Sucheck, S. J., Vogt, P. K., Wong, C. H. (2004). Inhibition of the proteolytic activity of anthrax lethal factor by aminoglycosides. J. Am. Chem. Soc. 126:4774-4775.
16. Leppla, S. H. (1998). Production and purification of anthrax toxin. In: Methods in Enzymology Academic Press: London, New York 165:103-116.
17. Levine, L. M., Michener, M. L., Toth, M. V., Holwerda, B. C. (1997). Measurement of specific protease activity utilizing fluorescence polarization. Anal. Biochem. 247:83-88.
18. Mikesell, P., Ivins, B. E., Ristroph, J. D., Dreier, T. M. (1983). Evidence for plasmid-mediated toxin production in Bacillus anthracis. Infect. Immun. 39:371-376.
19. Min, D. H., Tang, W. J., Mrksich, M. (2004). Chemical screening by mass spectrometry to identify inhibitors of anthrax lethal factor. Nat. Biotechnol. 22:717-723.
20. Mock, M., Fouet, A. (2001). Anthrax. Annu. Rev. Microbiol. 55:647-671.
21. Mock, M., Roques, B. P. (2002). Progress in rapid screening of Bacillus anthracis lethal factor activity. Proc. Natl. Acad. Sci. USA. 99:6527-6529.
22. Morton, N, Swartz, M. D. (2001). Recognition and management of anthrax. N. Engl. J. Med. 345:1621-1626.
23. Panchal, R. G., Hermone, A. R., Nguyen, T. L., Wong, T. Y., Schwarzenbacher, R., Schmidt, J., Lane, D., McGrath, C., Turk, B. E., Burnett, J., Aman, M. J., Little, S., Sausville, E. A., Zaharevitz, D. W., Cantley, L. C., Liddington, R. C., Gussio, R., Bavari, S. (2004). Identification of small molecule inhibitors of anthrax lethal factor. Nat. Struct. Mol. Biol. 11:67-72.
24. Pannifer, A. D., Wong, T. Y., Schwarzenbacher, R., Renatus, M., Petosa, C., Bienkowska, J., Lacy, D. B., Collier, R. J., Park, S., Leppla, S. H., Hanna, P., Liddington, R. C. (2001). Crystal structure of the anthrax lethal factor. Nature 414:229-233.
25. Park, J. M., Greten, F. R., Li, J. W., Karin, M. (2002). Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science 297:2048-2051.
26. Popov, S. G., Villasmil, R., Bernardi, J., Grene, E., Cardwell, J., Wu, A., Alibek, D., Bailey, C., Alibek, K. (2002). Lethal toxin of Bacillus anthracis causes apoptosis of macrophages. Biochem. Biophys. Res. Commun. 293:349-355.
27. Rivera, V. R., Merrill, G. A., White, J. A., Poli, M. A. (2003). An enzymatic electrochemiluminescence assay for the lethal factor of anthrax. Anal. Biochem. 321:125-130.
28. Salisbury, C. M., Maly, D. J., Ellman, J. A. (2002). Peptide microarrays for the determination of protease substrate specificity. J. Am. Chem. Soc. 124:14868-14870.
29. Tawa, P., Tam, J., Cassady, R., Nicholson, D. W., Xanthoudakis, S. (2001). Quantitative analysis of fluorescent caspase substrate cleavage in intact cells and identification of novel inhibitors of apoptosis. Cell Death Differ. 8:30-37.
30. Tonello, F., Seveso, M., Marin, O., Mock, M., Montecucco, C. (2002). Screening inhibitors of anthrax lethal factor. Nature 418:386.
31. Tonello, F., Ascenzi, P., Montecucco, C. (2003). The metalloproteolytic activity of the anthrax lethal factor is substrate-inhibited. J. Biol. Chem. 278:40075-40078.
32. Tonello, F., Naletto, L., Romanello, V., Dal Molin, F., Montecucco, C. (2004). Tyrosine-728 and glutamic acid-735 are essential for the metalloproteolytic activity of the lethal factor of Bacillus anthracis. Biochem. Biophys. Res. Commun. 16:496-502.
33. Turk, B. E., Wong, T. Y., Schwarzenbacher, R., Jarrell, E. T., Leppla, S. H., Collier, R. J., Liddington, R. C., Cantley, L. C. (2004). The structural basis for substrate and inhibitor selectivity of the anthrax lethal factor. Nat. Struct. Mol. Biol. 11:60-66.
34. Vitale, G., Pellizzari, R., Recchi, C., Napolitani, G., Mock, M., Montecucco, C. (1998). Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages. Biochem. Biophys. Res. Commun. 248:706-711.
35. Vitale, G., Bernardi, L., Napolitani, G., Mock, M., Montecucco, C. (2000). Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor. Biochem. J. 352:739-745.